Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.
These evidence-based guidelines have been produced after a systematic literature review of a range of issues involving prevention, diagnosis and treatment of hospital-acquired pneumonia (HAP). Prevention is structured into sections addressing general issues, equipment, patient procedures and the environment, whereas in treatment, the structure addresses the use of antimicrobials in prevention and treatment, adjunctive therapies and the application of clinical protocols. The sections dealing with diagnosis are presented against the clinical, radiological and microbiological diagnosis of HAP. Recommendations are also made upon the role of invasive sampling and quantitative microbiology of respiratory secretions in directing antibiotic therapy in HAP/ventilator-associated pneumonia.
Masterton
R G
RG
Department of Microbiology, Crosshouse Hospital, Kilmarnock, UK. robert.masterton@aaaht.scot.nhs.uk <robert.masterton@aaaht.scot.nhs.uk>
Galloway
A
A
French
G
G
Street
M
M
Armstrong
J
J
Brown
E
E
Cleverley
J
J
Dilworth
P
P
Fry
C
C
Gascoigne
A D
AD
Knox
Alan
A
Nathwani
Dilip
D
Spencer
Robert
R
Wilcox
Mark
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006113:United Kingdom
D000900:Anti-Bacterial Agents